Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 119694203 | 11969420 | 3 | F | 20160118 | 20160715 | 20160128 | 20160720 | PER | PHEH2016US001662 | NOVARTIS | 31.49 | YR | F | Y | 0.00000 | 20160720 | MD | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 119694203 | 11969420 | 1 | PS | AFINITOR | EVEROLIMUS | 1 | Oral | 10 MG, QD | U | 22334 | 10 | MG | TABLET | QD | |||||
| 119694203 | 11969420 | 2 | C | KLONOPIN | CLONAZEPAM | 1 | Unknown | U | 0 | ||||||||||
| 119694203 | 11969420 | 3 | C | HYDRALAZINE | HYDRALAZINE HYDROCHLORIDE | 1 | Unknown | U | 0 | ||||||||||
| 119694203 | 11969420 | 4 | C | KEPPRA | LEVETIRACETAM | 1 | Unknown | UNK | U | 0 | |||||||||
| 119694203 | 11969420 | 5 | C | METOPROLOL. | METOPROLOL | 1 | Unknown | U | 0 | ||||||||||
| 119694203 | 11969420 | 6 | C | LIPITOR | ATORVASTATIN CALCIUM | 1 | Unknown | U | 0 | ||||||||||
| 119694203 | 11969420 | 7 | C | LEVEMIR | INSULIN DETEMIR | 1 | Unknown | U | 0 | ||||||||||
| 119694203 | 11969420 | 8 | C | HUMALOG | INSULIN LISPRO | 1 | Unknown | U | 0 | ||||||||||
| 119694203 | 11969420 | 9 | C | CALCIUM ACETATE. | CALCIUM ACETATE | 1 | Unknown | U | 0 | ||||||||||
| 119694203 | 11969420 | 10 | C | VITAMIN D | CHOLECALCIFEROL | 1 | Unknown | U | 0 | ||||||||||
| 119694203 | 11969420 | 11 | C | MAGNESIUM | MAGNESIUM | 1 | Unknown | U | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 119694203 | 11969420 | 1 | Angiomyolipoma |
| 119694203 | 11969420 | 2 | Product used for unknown indication |
| 119694203 | 11969420 | 3 | Product used for unknown indication |
| 119694203 | 11969420 | 4 | Product used for unknown indication |
| 119694203 | 11969420 | 5 | Product used for unknown indication |
| 119694203 | 11969420 | 6 | Product used for unknown indication |
| 119694203 | 11969420 | 7 | Product used for unknown indication |
| 119694203 | 11969420 | 8 | Product used for unknown indication |
| 119694203 | 11969420 | 9 | Product used for unknown indication |
| 119694203 | 11969420 | 10 | Product used for unknown indication |
| 119694203 | 11969420 | 11 | Product used for unknown indication |
Outcome of event
| no results found |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 119694203 | 11969420 | Anxiety | |
| 119694203 | 11969420 | Diarrhoea | |
| 119694203 | 11969420 | Renal disorder |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 119694203 | 11969420 | 1 | 20150501 | 0 |